Atlas Trials

Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary

Clinical trial NCT03396471 · TERMINATED

Trial details

NCT number
NCT03396471
Sponsor
Hoosier Cancer Research Network
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Unspecified Site
Start date
2018-02-01
Primary completion
2021-08-12
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.